Imroatul Nasiyah
For decades, silicon chips have been the bedrock of our digital world, powering everything from personal computers to complex supercomputers. Their ability to process and store vast amounts of information has reshaped society. Now, these ubiquitous chips are transcending their computational origins and finding an entirely new, profound role in the field of biotechnology. Researchers are increasingly leveraging their precision and control to interact with and understand living systems. This includes their use in recording the intricate electrical activity of neurons, enabling us to decipher the language of the brain. They are also being employed to read the genetic blueprint of life, decoding DNA sequences to understand health and disease. The latest advancement, however, takes this integration a step further: these silicon chips are now actively creating DNA, acting as sophisticated biological printers.
The core innovation lies in a novel silicon chip capable of simultaneously synthesizing an impressive 64 distinct DNA sequences. This is a monumental achievement, especially when compared to the limitations of previous enzymatic DNA synthesis methods, which were largely confined to producing only a handful of sequences at a time. The Harvard team’s chip, however, has shattered this barrier, producing 64 unique sequences in parallel, each reaching a length of up to 39 nucleotides. This milestone establishes a new benchmark for enzymatic DNA synthesis, bringing it closer to matching the parallelization capabilities of conventional chemical methods.
The significance of this development is amplified when considering the current landscape of synthetic DNA production. Synthetic DNA is an indispensable tool across numerous scientific and medical disciplines. It is critical for the development of advanced diagnostics, for precise genome engineering that allows us to modify genetic material, and for cutting-edge cancer research, where synthetic DNA can be used to develop targeted therapies. The dominant method for producing custom DNA today is phosphoramidite chemistry. While highly effective and capable of generating millions of DNA sequences in parallel, this method carries significant drawbacks. It relies heavily on hazardous organic solvents, posing environmental and safety concerns, and typically requires specialized, centralized manufacturing facilities. This often limits accessibility and increases the cost of custom DNA production.
In contrast, enzymatic DNA synthesis offers a far gentler and more environmentally friendly alternative. This approach utilizes water as its primary medium, mirroring the elegant and efficient way that living cells naturally construct DNA. The potential benefits are substantial: smaller, safer, and more widely available DNA synthesis systems could emerge, democratizing access to this vital technology. However, until the work of Ham’s team, enzymatic methods have struggled to compete with the throughput of conventional chemical synthesis. The ability to synthesize multiple sequences simultaneously has been a major bottleneck, with prior demonstrations limited to approximately a dozen sequences. The Harvard team’s success in synthesizing 64 sequences in parallel marks a pivotal moment, bridging this critical gap and paving the way for broader adoption of enzymatic DNA synthesis.
The ingenious mechanism by which the silicon chip writes DNA is a testament to the researchers’ innovative thinking. DNA is constructed by adding nucleotides, the fundamental building blocks, one at a time. After each nucleotide is incorporated, a temporary blocking group is attached to the growing DNA strand. This group prevents further nucleotides from being added, ensuring that the DNA chain grows in a controlled manner. Before the next nucleotide can be attached, this blocking group must be removed through a process known as deprotection. This deprotection step is typically triggered by acidic conditions, or a low pH environment, within an aqueous solution.
The challenge in synthesizing multiple DNA sequences concurrently lies in selectively lowering the pH only at specific locations on the chip during each synthesis cycle. The Harvard chip masterfully accomplishes this feat through the precise application of tiny electrical currents. The chip’s surface is meticulously engineered with 64 distinct synthesis sites. Each of these sites is outfitted with a sophisticated arrangement of two concentric ring electrodes, with the DNA molecules to be synthesized anchored at the very center. When a particular synthesis site is activated, the inner ring electrode generates a localized flow of protons. This influx of protons creates a micro-environment with a reduced pH, precisely at that site, enabling the DNA strand to extend. Simultaneously, the outer ring electrode works to actively remove protons that might diffuse outward from the reaction zone. This dual-electrode system effectively confines the acidic region to the intended synthesis site, preventing cross-contamination and ensuring the integrity of each independent DNA sequence. By repeating this cycle of controlled proton generation and removal, the chip can independently build 64 unique DNA sequences, each with its own specific order of nucleotides, across its surface.
Intriguingly, the silicon chip was not initially conceived for DNA synthesis. Its origins lie in the realm of neuroscience and brain research. Jeffrey Abbott, a former PhD student in Professor Ham’s laboratory, originally developed this sophisticated silicon electronics platform for the purpose of recording the electrical activity within large populations of neurons. The platform was designed to offer unprecedented precision in probing the complex signaling within neural networks. It was through a process of inspired redesign and adaptation that the researchers discovered the chip’s latent capability for DNA synthesis. By reconfiguring the surface electrodes and understanding the fundamental principles of electrochemical control, they realized that the same underlying technology could be repurposed to precisely manage the chemical conditions required for DNA synthesis.
Professor Ham explained this serendipitous discovery: "A defining feature of the chip was precision current injection, which we used to permeabilize neuronal membranes for intracellular access. At a certain point, we wondered whether that same current control could be redirected from cells to molecules, replacing the neuron-facing electrodes with ring-electrode pairs that could localize pH for DNA synthesis. It worked." This remarkable pivot from studying brain activity to writing genetic code highlights the versatility and power of precisely engineered microelectronic devices.
Beyond its immediate applications in synthetic biology and medical diagnostics, the Harvard team has also demonstrated another compelling potential use for their DNA writing machine: data storage. In a proof-of-concept experiment, the 64 synthesized DNA sequences were employed to encode a small but significant piece of digital information – a 169-byte text. While DNA-based data storage remains a long-term aspiration, largely due to the immense scale of DNA synthesis required to store vast amounts of data, this demonstration underscores the future possibilities. The researchers believe that their water-based enzymatic synthesis approach could become increasingly attractive as production volumes for DNA data storage escalate. By significantly reducing or eliminating the use of hazardous organic solvents, this method offers a more environmentally sustainable pathway for large-scale DNA manufacturing, a crucial consideration for future data archiving solutions.
Woo-Bin Jung, a co-first author of the study and now an assistant professor at the Pohang University of Science and Technology (POSTECH), who conducted the work as a postdoctoral researcher in Ham’s lab, elaborated on this point: "DNA data storage asks DNA synthesis to operate at a scale far beyond today’s needs. That is why enzymatic synthesis in water can matter. If far more than 64 sequences can be synthesized in parallel, it could offer an environmentally friendly route toward writing DNA at very large scale."
Despite the remarkable success, the researchers acknowledge that chemistry remains a critical area for future development. They sought to understand the limits of scalability for their chip design and fabricated new chips with synthesis sites placed even closer together, aiming to achieve even higher densities of parallel DNA production. While this experiment did not yield the expected increase in the number of simultaneously synthesized sequences, it provided a crucial insight into the limiting factors. The silicon chip itself proved to be highly effective at confining the low pH to the intended reaction sites, demonstrating its precision. The true bottleneck, it turned out, was not the chip’s physical confinement but rather the chemistry involved in the deprotection step.
In the current enzymatic synthesis process, low pH does not directly remove the blocking groups. Instead, it generates intermediate molecules that then carry out the deprotection. The challenge arises because these intermediate molecules can, to some extent, diffuse into neighboring synthesis sites. This diffusion can blur the boundaries between adjacent reactions, even though the pH itself is precisely controlled at each site. This effectively limits the density at which independent reactions can occur.
Han Sae Jung, another co-first author of the study and a current postdoctoral researcher at Harvard, summarized this finding: "The chip did what we asked it to do: it localized low pH at selected sites. The limitation came from the deprotection chemistry, not from the silicon. That leaves a clear next step for the field — develop a more direct acid-driven deprotection chemistry that can keep pace with the chip." This clearly defines the path forward for researchers aiming to further enhance the throughput and density of enzymatic DNA synthesis.
This groundbreaking project was a testament to collaborative scientific endeavor, involving researchers from Harvard University, the Broad Institute, and the company DNA Script, with later contributions from POSTECH. The intellectual property associated with this innovative platform has been secured through filings by Harvard’s Office of Technology Development. The study, titled "Parallel enzymatic DNA synthesis using a semiconductor chip," received significant support from various funding bodies, including the Office of the Director of National Intelligence (ODNI) via the Intelligence Advanced Research Projects Activity (IARPA), Horizon Europe under the Hyperion project, and the Samsung Research Funding & Incubation Center for Future Technology of Samsung Electronics. This multifaceted support underscores the broad recognition of the importance and potential impact of this revolutionary technology.
